These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3262229

  • 1. [Cell-mediated immunity in drug addicts: interaction of opiates and naloxone on natural cytotoxic activity and immune-mediated reactions of phagocytes].
    Ventura MT, Serlenga E, Antonaci S, Jirillo E, Bonomo L.
    Recenti Prog Med; 1988 Jun; 79(6):241-5. PubMed ID: 3262229
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Density of immunoreactive cells in the spleen in drug fatalities].
    Köster E, Cardauns H, Oehmichen M, Staak M.
    Beitr Gerichtl Med; 1990 Jun; 48():67-73. PubMed ID: 2241857
    [Abstract] [Full Text] [Related]

  • 5. Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.
    Adelson MO, Novick DM, Khuri E, Albeck H, Hahn EF, Kreek MJ.
    Isr J Med Sci; 1994 Sep; 30(9):679-84. PubMed ID: 8088979
    [Abstract] [Full Text] [Related]

  • 6. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F, Manzato E, Lucchini A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1089-94. PubMed ID: 17466429
    [Abstract] [Full Text] [Related]

  • 7. [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].
    Brugo MA, Guffanti A, Guzzetti S, Pedretti D, Stringhetti M, Confalonieri F.
    Boll Ist Sieroter Milan; 1983 Jun 30; 62(6):517-23. PubMed ID: 6234006
    [Abstract] [Full Text] [Related]

  • 8. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS, Gordon M, Pachter IJ.
    Proc Natl Conf Methadone Treat; 1973 Jun 30; 2():1336-41. PubMed ID: 4215978
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May 30; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absence of morphine-binding activity in serum from heroin addicts.
    Weksler ME, Cherubin C, Kilcoyne M, Koppel G, Yoel M.
    Clin Exp Immunol; 1973 Apr 30; 13(4):613-7. PubMed ID: 4717097
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug abuse in Asia.
    Suwanwela C, Poshyachinda V.
    Bull Narc; 1986 Apr 30; 38(1-2):41-53. PubMed ID: 3535959
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of cellular immunity in drug addicts].
    Irola Bernal E, Di Cugno F, Molgatini S, Barrientos O, Negroni de Bonvehí M.
    Rev Argent Microbiol; 1982 Apr 30; 14(3):119-28. PubMed ID: 6765623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.